Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity
Article first published online: 30 DEC 2003
Copyright © 1998 American Association for the Study of Liver Diseases
Volume 27, Issue 3, pages 868–872, March 1998
How to Cite
Mathurin, P., Moussalli, J., Cadranel, J.-F., Thibault, V., Charlotte, F., Dumouchel, P., Cazier, A., Huraux, J.-M., Devergie, B., Vidaud, M., Opolon, P. and Poynard, T. (1998), Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology, 27: 868–872. doi: 10.1002/hep.510270333
- Issue published online: 30 DEC 2003
- Article first published online: 30 DEC 2003
- Manuscript Accepted: 13 NOV 1997
- Manuscript Received: 20 AUG 1997
- Association pour la Recherche contre le Cancer, France
- 3Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. Metavir and Clinivir Cooperative Study Groups. J Viral Hepat 1997; 4:199–208.MEDLINE, .
- 14Liver histology in asymptomatic anti-HCV patients with normal ALT levels. Hepatology 1994; 20:255A., , , , , , .
- 18Levels of HCV RNA in subjects with and without HCV-related chronic liver disease [Abstract]. J Hepatol 1995; 23(Suppl:A25., , , , , .
- 22Level of viremia, genotype, histological features and effect of interferon (IFN) therapy in hepatitis C virus (HCV) carriers with persistently normal ALT activity. Hepatology 1994; 20:165A., , , , , .